Oral drug treatment helps protect cancer patients from potentially deadly blood clots

A tablet could help protect cancer patients from a potentially deadly condition, researchers from the University of Warwick have found. People with cancer have an increased risk of developing blood clots, with roughly one in five experiencing venous thromboembolism (VTE) – either deep vein thrombosis (DVT) or pulmonary embolism (PE). Blood clots in the deep veins of the leg may travel to the lungs causing a pulmonary embolism. Current international guidelines recommend cancer patients are injected with an anticoagulant (a low molecular weight heparin) to treat and prevent recurrence of VTE. However, new results from a large pilot trial run at the